The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Chinese herbal medicine Shufeng Jiedu capsule for mild to moderate COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase II trial
|
|---|---|
| Published in |
Frontiers in Pharmacology, May 2024
|
| DOI | 10.3389/fphar.2024.1383831 |
| Pubmed ID | |
| Authors |
Chun-li Lu, Liu-qing Yang, Xin-yan Jin, Thomas Friedemann, Yu-fei Li, Xue-han Liu, Xiao-ying Chen, Xiang-yun Zou, Bing-rui Zhang, Fu-xiang Wang, Yuan-long Lin, Yi-min Tang, Meng-li Cao, Ya-lin Jiang, You-fang Gao, Kui Liu, Zhen-gang Tao, Nicola Robinson, Sven Schröder, Jian-ping Liu, Hong-zhou Lu |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 7 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 July 2024.
All research outputs
#8,219,538
of 26,215,093 outputs
Outputs from Frontiers in Pharmacology
#3,768
of 20,174 outputs
Outputs of similar age
#77,562
of 262,736 outputs
Outputs of similar age from Frontiers in Pharmacology
#40
of 157 outputs
Altmetric has tracked 26,215,093 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 20,174 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 262,736 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 157 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.